MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/18/1338/001  Dengvaxia   
--¹ 
EU/1/18/1338/002  Dengvaxia   
--¹ 
EU/1/18/1338/003  Dengvaxia   
--¹ 
EU/1/18/1338/004  Dengvaxia   
--¹ 
EU/1/18/1338/005  Dengvaxia   
--¹ 
Powder and solvent 
for suspension for 
injection 
Powder and solvent 
for suspension for 
injection 
Powder and solvent 
for suspension for 
injection 
Powder and solvent 
for suspension for 
injection 
Powder and solvent 
for suspension for 
injection 
Subcutaneous use  powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass) 
Subcutaneous use  powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass) 
Subcutaneous use  powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass) 
Subcutaneous use  powder: vial 
(glass); solvent: 
pre-filled syringe 
(glass) 
Powder: 1 dose; 
solvent: 0.5 ml 
1 vial + 1 pre-filled 
syringe + 2 needles  
Powder: 1 dose; 
solvent: 0.5 ml 
10 vials + 10 
pre-filled syringes + 
20 needles  
Powder: 1 dose; 
solvent: 0.5 ml 
1 vial + 1 pre-filled 
syringe  
Powder: 1 dose; 
solvent: 0.5 ml 
10 vials + 10 
pre-filled syringes  
Subcutaneous use  powder: vial 
(glass); solvent: 
vial (glass) 
Powder: 5 doses; 
solvent: 2.5 ml 
5 sets of 2 vials (1 
with powder + 1 
with solvent, 5 
doses each)  
--¹  After reconstitution, one dose (0.5 mL) contains: 
Chimeric yellow fever dengue virus serotype 1* (live, attenuated).............................................4.5 - 6.0 log10 CCID50/dose** 
Chimeric yellow fever dengue virus serotype 2* (live, attenuated).............................................4.5 - 6.0 log10 CCID50/dose** 
Chimeric yellow fever dengue virus serotype 3* (live, attenuated).............................................4.5 - 6.0 log10 CCID50/dose** 
Chimeric yellow fever dengue virus serotype 4* (live, attenuated).............................................4.5 - 6.0 log10 CCID50/dose** 
* Produced in Vero cells by recombinant DNA technology. This product contains genetically modified organisms (GMOs). 
** CCID50: 50% Cell Culture Infectious Dose. 
 
 
 
  
 
 
 
 
 
 
 
 
